ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 45 filers reported holding ZOSANO PHARMA CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | -50.0% | 21,297 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -33.3% | 21,297 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | -25.0% | 21,297 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -23.1% | 21,297 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +136.4% | 21,297 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | -68.6% | 21,297 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | +94.4% | 21,297 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +50.0% | 21,297 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -62.5% | 21,297 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | -3.0% | 21,297 | 0.0% | 0.00% | – |
| Q3 2019 | $33,000 | -52.9% | 21,297 | 0.0% | 0.00% | – |
| Q2 2019 | $70,000 | -31.4% | 21,297 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $102,000 | +126.7% | 21,297 | 0.0% | 0.00% | – |
| Q4 2018 | $45,000 | -48.3% | 21,297 | 0.0% | 0.00% | – |
| Q3 2018 | $87,000 | +31.8% | 21,297 | +30.7% | 0.00% | – |
| Q2 2018 | $66,000 | – | 16,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 526,741 | $278,000 | 0.47% |
| Aisling Capital Management LP | 2,718,226 | $1,433,000 | 0.25% |
| Sio Capital Management, LLC | 427,542 | $225,000 | 0.05% |
| Virtu Financial LLC | 198,673 | $105,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 121,978 | $64,000 | 0.01% |
| Wealthcare Advisory Partners LLC | 68,754 | $36,000 | 0.00% |
| Highlander Capital Management, LLC | 10,000 | $5,000 | 0.00% |
| WINTON GROUP Ltd | 66,873 | $35,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 60,000 | $32,000 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $527,000 | 0.00% |